| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.79e-11 | 37 | 121 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.04e-11 | 38 | 121 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 KDM5B TRIT1 POLR2A ZNF407 CHD3 ZMAT4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 AR BLVRA PHF2 ERVK-8 KMT2A ERVK-19 ERVK-24 AGBL1 ALPG | 3.91e-07 | 891 | 121 | 20 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.10e-07 | 11 | 121 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.23e-06 | 14 | 121 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.81e-06 | 37 | 121 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.22e-06 | 38 | 121 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.09e-06 | 21 | 121 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 TRIT1 POLR2A ETF1 RPP38 CHD3 ERVK-7 MSH3 ERVK-10 AARSD1 BPTF ERVK-8 RARS2 DHX35 DDX4 | 8.42e-06 | 645 | 121 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 8.45e-06 | 46 | 121 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 TRIT1 POLR2A ETF1 RPP38 ERVK-7 ERVK-10 AARSD1 ERVK-8 RARS2 DHX35 DDX4 | 8.84e-06 | 417 | 121 | 12 | GO:0140098 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 MYH6 MYH8 KIF27 MYO1E ABCB5 CHD3 MSH3 ABCA10 BPTF DHX35 DDX4 SLC27A4 | 2.14e-05 | 614 | 121 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 KDM5B TRIT1 POLR2A ZNF407 CHD3 ZMAT4 ERVK-7 ERVK-21 ERVK-9 ERVK-10 AR BLVRA PHF2 ERVK-8 KMT2A ERVK-19 ERVK-24 AGBL1 ALPG | 2.98e-05 | 1189 | 121 | 20 | GO:0046914 |
| GeneOntologyMolecularFunction | DNA polymerase activity | 8.07e-05 | 38 | 121 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.29e-05 | 118 | 121 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.18e-04 | 79 | 121 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.10e-04 | 230 | 121 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 5.71e-04 | 27 | 121 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 6.02e-04 | 112 | 121 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.10e-03 | 262 | 121 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 1.17e-03 | 265 | 121 | 7 | GO:0042393 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 MYH3 MYH6 MYH8 ETF1 RPP38 ERVK-7 ERVK-10 UBLCP1 AARSD1 PLCD3 ERVK-8 ALPG | 1.23e-03 | 807 | 121 | 13 | GO:0016788 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24 CTSK | 1.24e-03 | 430 | 121 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 1.44e-03 | 136 | 121 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 1.44e-03 | 136 | 121 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.47e-03 | 441 | 121 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.78e-03 | 85 | 121 | 4 | GO:0017018 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 1.78e-03 | 85 | 121 | 4 | GO:0008135 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 1.85e-03 | 144 | 121 | 5 | GO:0140101 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.34e-03 | 152 | 121 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | actin binding | 2.58e-03 | 479 | 121 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 MYH8 KIF27 MYO1E ABCB5 CHD3 ABCA10 OPA1 GUF1 TSR1 DHX35 DDX4 | 2.63e-03 | 775 | 121 | 12 | GO:0017111 |
| GeneOntologyBiologicalProcess | DNA integration | 6.76e-07 | 13 | 117 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.28e-06 | 15 | 117 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 2.83e-06 | 18 | 117 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.23e-04 | 85 | 117 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.23e-04 | 85 | 117 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.53e-04 | 89 | 117 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.58e-04 | 48 | 117 | 4 | GO:0000731 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.84e-06 | 16 | 121 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.23e-05 | 25 | 121 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.96e-05 | 28 | 121 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 2.33e-05 | 59 | 121 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 1.98e-04 | 4 | 121 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.40e-04 | 96 | 121 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 9.29e-04 | 129 | 121 | 5 | GO:1904949 | |
| Domain | Myosin_N | 1.53e-06 | 15 | 111 | 4 | PF02736 | |
| Domain | Myosin_N | 1.53e-06 | 15 | 111 | 4 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 2.91e-06 | 38 | 111 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.91e-06 | 38 | 111 | 5 | PS51456 | |
| Domain | Myosin_head | 2.91e-06 | 38 | 111 | 5 | PF00063 | |
| Domain | MYSc | 2.91e-06 | 38 | 111 | 5 | SM00242 | |
| Domain | Myosin_tail_1 | 3.39e-06 | 18 | 111 | 4 | PF01576 | |
| Domain | Myosin_tail | 3.39e-06 | 18 | 111 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.28e-06 | 19 | 111 | 4 | IPR027401 | |
| Domain | - | 4.28e-06 | 19 | 111 | 4 | 4.10.270.10 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH6 TRIT1 MYH8 KIF27 MYO1E ABCB5 CHD3 MSH3 ABCA10 OPA1 GUF1 TRANK1 DHX35 DDX4 | 4.05e-05 | 848 | 111 | 16 | IPR027417 |
| Domain | IQ | 6.45e-05 | 71 | 111 | 5 | PF00612 | |
| Domain | PHD | 8.39e-05 | 75 | 111 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 1.08e-04 | 79 | 111 | 5 | IPR019787 | |
| Domain | PHD | 1.89e-04 | 89 | 111 | 5 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 1.99e-04 | 90 | 111 | 5 | IPR000048 | |
| Domain | Znf_PHD | 2.10e-04 | 91 | 111 | 5 | IPR001965 | |
| Domain | PPIase_FKBP_dom | 2.16e-04 | 20 | 111 | 3 | IPR001179 | |
| Domain | IQ | 2.32e-04 | 93 | 111 | 5 | PS50096 | |
| Domain | ZF_PHD_2 | 2.56e-04 | 95 | 111 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.69e-04 | 96 | 111 | 5 | PS01359 | |
| Domain | Znf_C2H2_jaz | 2.90e-04 | 22 | 111 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 2.90e-04 | 22 | 111 | 3 | PF12171 | |
| Domain | Alpha_kinase | 5.17e-04 | 6 | 111 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 5.17e-04 | 6 | 111 | 2 | IPR004166 | |
| Domain | ALPHA_KINASE | 5.17e-04 | 6 | 111 | 2 | PS51158 | |
| Domain | Alpha_kinase | 5.17e-04 | 6 | 111 | 2 | SM00811 | |
| Domain | Zinc_finger_PHD-type_CS | 6.05e-04 | 65 | 111 | 4 | IPR019786 | |
| Domain | Znf_U1 | 6.67e-04 | 29 | 111 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 6.67e-04 | 29 | 111 | 3 | SM00451 | |
| Domain | IQ | 1.38e-03 | 81 | 111 | 4 | SM00015 | |
| Domain | PH_DOMAIN | 1.39e-03 | 279 | 111 | 7 | PS50003 | |
| Domain | PH_domain | 1.42e-03 | 280 | 111 | 7 | IPR001849 | |
| Domain | BROMODOMAIN_2 | 1.85e-03 | 41 | 111 | 3 | PS50014 | |
| Domain | Znf_FYVE_PHD | 1.85e-03 | 147 | 111 | 5 | IPR011011 | |
| Domain | Bromodomain | 1.98e-03 | 42 | 111 | 3 | IPR001487 | |
| Domain | BROMO | 1.98e-03 | 42 | 111 | 3 | SM00297 | |
| Domain | - | 1.98e-03 | 42 | 111 | 3 | 1.20.920.10 | |
| Domain | Ribosomal_L7Ae/L30e/S12e/Gad45 | 2.22e-03 | 12 | 111 | 2 | IPR004038 | |
| Domain | - | 3.49e-03 | 15 | 111 | 2 | 3.30.1330.30 | |
| Domain | L30e-like | 3.49e-03 | 15 | 111 | 2 | IPR029064 | |
| Domain | CBS | 3.98e-03 | 16 | 111 | 2 | SM00116 | |
| Domain | AT_hook | 3.98e-03 | 16 | 111 | 2 | PF02178 | |
| Domain | FKBP_PPIASE | 3.98e-03 | 16 | 111 | 2 | PS50059 | |
| Domain | FKBP_C | 3.98e-03 | 16 | 111 | 2 | PF00254 | |
| Domain | PPIase_FKBP | 4.49e-03 | 17 | 111 | 2 | IPR023566 | |
| Domain | - | TRIT1 MYO1E ABCB5 CHD3 MSH3 ABCA10 OPA1 GUF1 TRANK1 DHX35 DDX4 | 4.84e-03 | 746 | 111 | 11 | 3.40.50.300 |
| Domain | ZF_MATRIN | 5.03e-03 | 18 | 111 | 2 | PS50171 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.44e-10 | 4 | 122 | 4 | 10469592 | |
| Pubmed | 3.80e-10 | 12 | 122 | 5 | 14557543 | ||
| Pubmed | FKBP15 EDF1 POLR2A ETF1 CHD3 MSH3 UBLCP1 PGK1 BLVRA SART1 WDR3 BPTF TSR1 CSNK2A1 ASS1 ZBTB21 MKI67 KMT2A SMARCC2 TAF1 | 4.17e-10 | 1014 | 122 | 20 | 32416067 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 7.19e-10 | 5 | 122 | 4 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.57e-09 | 94 | 122 | 8 | 21542922 | |
| Pubmed | EDF1 ARHGAP15 BICRA ETF1 BAG1 CHD3 POGZ PGK1 SART1 PHF2 PRR12 BPTF IGF2BP2 CSNK2A1 ZBTB21 MKI67 KMT2A SMARCC2 SDCBP RPL9 | 1.76e-09 | 1103 | 122 | 20 | 34189442 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SRSF5 POLR2A RPP38 CHD3 POGZ CBS SART1 WDR3 BPTF MKI67 KMT2A SMARCC2 | 3.22e-09 | 341 | 122 | 12 | 32971831 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIF27 SRSF5 POLR2A ETF1 MSH3 POGZ SEC31A CBS PGK1 OPA1 TSFM EIF3CL SART1 WDR3 PHF2 TSR1 AIFM1 CSNK2A1 MKI67 SDCBP RPL9 SLC27A4 | 4.74e-09 | 1425 | 122 | 22 | 30948266 |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 16819597 | ||
| Pubmed | ROCK2 MYH2 MYH3 MYH6 MYH8 ABCB5 BAG1 CHD3 UBLCP1 PGK1 FER1L6 SART1 BPTF CLCN5 ITSN2 ZBTB21 MTTP KMT2A SMARCC2 RPL9 SLC27A4 CFAP46 | 5.87e-09 | 1442 | 122 | 22 | 35575683 | |
| Pubmed | BICRA POLR2A RPP38 CHD3 POGZ OPA1 SART1 PHF2 BPTF IGF2BP2 ACTR6 CSNK2A1 ASS1 ZBTB21 SMARCC2 RARS2 TAF1 TAF4B AGBL1 | 1.29e-08 | 1116 | 122 | 19 | 31753913 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FKBP15 KDM5B EDF1 SRSF5 POLR2A POGZ SEC31A OPA1 AARSD1 SART1 PHF2 BPTF IGF2BP2 TSR1 CSNK2A1 SMARCC2 DHX35 ALPG | 4.61e-08 | 1082 | 122 | 18 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | POLR2A RPP38 MSH3 POGZ SEC31A PGK1 AARSD1 PLCD3 BLVRA SART1 WDR3 GUF1 IGF2BP2 AIFM1 A2ML1 ASS1 MKI67 SMARCC2 RPL9 SLC27A4 | 5.29e-08 | 1353 | 122 | 20 | 29467282 |
| Pubmed | SRSF5 POLR2A POGZ PGK1 SART1 WDR3 BPTF IGF2BP2 TSR1 CSNK2A1 MKI67 KMT2A SMARCC2 RPL9 | 7.82e-08 | 653 | 122 | 14 | 22586326 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 20357587 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 25315959 | ||
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 7983737 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CHD3 MSH3 POGZ PHF2 BPTF TSR1 CSNK2A1 CCNL1 ZBTB21 MKI67 KMT2A SMARCC2 TAF1 | 2.42e-07 | 608 | 122 | 13 | 36089195 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | BICRA POLR2A CHD3 MSH3 POGZ EIF3CL PHF2 BPTF MKI67 KMT2A SMARCC2 TAF1 | 4.19e-07 | 533 | 122 | 12 | 30554943 |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 4.19e-07 | 5 | 122 | 3 | 3829126 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 6196357 | ||
| Pubmed | 4.25e-07 | 18 | 122 | 4 | 18664271 | ||
| Pubmed | 4.78e-07 | 268 | 122 | 9 | 33640491 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.89e-07 | 351 | 122 | 10 | 38297188 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 EDF1 SRSF5 MYO1E POLR2A ETF1 SEC31A CBS PGK1 OPA1 SART1 TSR1 AIFM1 CSNK2A1 ASS1 SMARCC2 GOLGA2 SDCBP RPL9 | 5.13e-07 | 1415 | 122 | 19 | 28515276 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.25e-07 | 271 | 122 | 9 | 32433965 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 SRSF5 POLR2A CHD3 POGZ EIF3CL SART1 BPTF CSNK2A1 CCNL1 ZBTB21 MKI67 KMT2A SMARCC2 | 6.06e-07 | 774 | 122 | 14 | 15302935 |
| Pubmed | ROCK2 BAG1 RPP38 SEC31A CBS UBLCP1 TSFM BLVRA SART1 WDR3 BPTF TSR1 AIFM1 CSNK2A1 ASS1 MKI67 SMARCC2 SDCBP | 6.60e-07 | 1297 | 122 | 18 | 33545068 | |
| Pubmed | 8.24e-07 | 21 | 122 | 4 | 12453419 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 8.36e-07 | 6 | 122 | 3 | 10077619 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 15063128 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 8.36e-07 | 6 | 122 | 3 | 10588881 | |
| Pubmed | 1.00e-06 | 22 | 122 | 4 | 24301466 | ||
| Pubmed | EDF1 SRSF5 MYO1E RPP38 CHD3 POGZ PGK1 TSFM WDR3 PHF2 IGF2BP2 TSR1 AIFM1 CSNK2A1 MKI67 KMT2A SMARCC2 GOLGA2 | 1.46e-06 | 1371 | 122 | 18 | 36244648 | |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 35210422 | ||
| Pubmed | SRSF5 MYO1E POLR2A POGZ SART1 IGF2BP2 TSR1 AIFM1 KMT2A SMARCC2 GOLGA2 RPL9 | 1.47e-06 | 601 | 122 | 12 | 33658012 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | POLR2A ETF1 OPA1 SART1 TRANK1 CSNK2A1 ASS1 KMT2A CSNK2A3 GOLGA2 SDCBP | 1.53e-06 | 497 | 122 | 11 | 36774506 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 1.59e-06 | 400 | 122 | 10 | 35013556 | |
| Pubmed | 1.68e-06 | 102 | 122 | 6 | 26584622 | ||
| Pubmed | SRSF5 CHD3 SART1 WDR3 PRR12 IGF2BP2 TSR1 A2ML1 MKI67 KMT2A SMARCC2 CSNK2A3 GOLGA2 RPL9 | 1.75e-06 | 847 | 122 | 14 | 35850772 | |
| Pubmed | ROCK2 SRSF5 POLR2A ETF1 PGK1 OPA1 SART1 IGF2BP2 TSR1 AIFM1 ASS1 MKI67 SMARCC2 DHX35 PATJ GOLGA2 RPL9 | 1.77e-06 | 1247 | 122 | 17 | 27684187 | |
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 2.33e-06 | 8 | 122 | 3 | 1974879 | |
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 2.33e-06 | 8 | 122 | 3 | 1675191 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 2.33e-06 | 8 | 122 | 3 | 2034279 | |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 3864153 | ||
| Pubmed | KDM5B CFAP91 HIVEP2 MYO1E TRPM7 MSH3 POGZ SEC31A CBS PGK1 WDR3 GUF1 ASB3 DENND6B DHX35 TAF1 SDCBP | 2.65e-06 | 1285 | 122 | 17 | 35914814 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.80e-06 | 332 | 122 | 9 | 32786267 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SRSF5 BTBD10 RPP38 CHD3 SART1 WDR3 BPTF IGF2BP2 TSR1 AIFM1 MKI67 KCTD20 RPL9 | 2.85e-06 | 759 | 122 | 13 | 35915203 |
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 3.48e-06 | 9 | 122 | 3 | 7874112 | |
| Pubmed | 3.56e-06 | 438 | 122 | 10 | 32628020 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 12970426 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 2055107 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 4.96e-06 | 10 | 122 | 3 | 8950513 | |
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 6.81e-06 | 11 | 122 | 3 | 2034278 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO1E BTBD10 ETF1 PGK1 EIF3CL SART1 WDR3 IGF2BP2 TSR1 CSNK2A1 ASS1 MKI67 KCTD20 PATJ GOLGA2 RPL9 | 8.68e-06 | 1257 | 122 | 16 | 36526897 |
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 9.05e-06 | 12 | 122 | 3 | 28600496 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | EDF1 MYO1E RPP38 PLEKHJ1 POGZ SEC31A BLVRA SART1 IGF2BP2 MKI67 DHX35 RPL9 | 9.74e-06 | 724 | 122 | 12 | 36232890 |
| Pubmed | EDF1 SRSF5 POLR2A CBS SART1 IGF2BP2 TSR1 CSNK2A1 SMARCC2 PATJ RPL9 | 1.15e-05 | 615 | 122 | 11 | 31048545 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.17e-05 | 13 | 122 | 3 | 8404542 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 37580696 | ||
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 1.17e-05 | 13 | 122 | 3 | 1740345 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 8012115 | ||
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 1.17e-05 | 13 | 122 | 3 | 1772416 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 8948582 | ||
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 7805729 | ||
| Pubmed | Clinicopathologic significance of BAG1 and TIMP3 expression in colon carcinoma. | 1.22e-05 | 2 | 122 | 2 | 17657847 | |
| Pubmed | Human intersectin 2 (ITSN2) binds to Eps8 protein and enhances its degradation. | 1.22e-05 | 2 | 122 | 2 | 22449706 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 1.22e-05 | 2 | 122 | 2 | 14646071 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22534467 | ||
| Pubmed | Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer. | 1.22e-05 | 2 | 122 | 2 | 28826504 | |
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 1.22e-05 | 2 | 122 | 2 | 12860116 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18381083 | ||
| Pubmed | Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk. | 1.22e-05 | 2 | 122 | 2 | 31366519 | |
| Pubmed | CK2 phosphorylates Sec31 and regulates ER-To-Golgi trafficking. | 1.22e-05 | 2 | 122 | 2 | 23349870 | |
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 1.22e-05 | 2 | 122 | 2 | 1577469 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.22e-05 | 2 | 122 | 2 | 9460924 | |
| Pubmed | The androgen receptor has no direct antiresorptive actions in mouse osteoclasts. | 1.22e-05 | 2 | 122 | 2 | 25958043 | |
| Pubmed | Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity. | 1.22e-05 | 2 | 122 | 2 | 11278763 | |
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 1.22e-05 | 2 | 122 | 2 | 2752008 | |
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 1.22e-05 | 2 | 122 | 2 | 8420794 | |
| Pubmed | Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. | 1.22e-05 | 2 | 122 | 2 | 24523409 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF5 POLR2A RPP38 CHD3 MSH3 POGZ SART1 WDR3 PHF2 PRR12 BPTF ACTR6 MKI67 KMT2A SDCBP SLC27A4 | 1.24e-05 | 1294 | 122 | 16 | 30804502 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SRSF5 POLR2A POGZ PGK1 EIF3CL SART1 TSR1 AIFM1 ITSN2 ASS1 MKI67 SMARCC2 DHX35 GOLGA2 ALPG | 1.34e-05 | 1155 | 122 | 15 | 20360068 |
| Pubmed | 1.49e-05 | 14 | 122 | 3 | 27184118 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.52e-05 | 410 | 122 | 9 | 26949251 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.56e-05 | 313 | 122 | 8 | 38270169 | |
| Pubmed | Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. | 1.86e-05 | 15 | 122 | 3 | 14992727 | |
| Pubmed | CHD3 WLS PLCD3 PRR12 TSR1 ASB3 CARD6 KMT2A PATJ GOLGA2 SLC27A4 | 1.92e-05 | 650 | 122 | 11 | 38777146 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | FKBP15 MYH2 MYH3 MYH6 MYH8 SRSF5 NLRX1 EIF3CL AIFM1 CSNK2A1 KMT2A CSNK2A3 GOLGA2 | 1.97e-05 | 910 | 122 | 13 | 36736316 |
| Pubmed | 2.02e-05 | 157 | 122 | 6 | 30186101 | ||
| Pubmed | 2.28e-05 | 16 | 122 | 3 | 22090424 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | EPS8 SRSF5 POLR2A ETF1 POGZ HIBADH TSR1 CSNK2A1 MKI67 CTSK FKBP2 | 2.54e-05 | 670 | 122 | 11 | 22990118 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FKBP15 EDF1 POLR2A ETF1 CHD3 CBS PGK1 IGF2BP2 ZBTB21 MKI67 KMT2A SDCBP RPL9 | 2.58e-05 | 934 | 122 | 13 | 33916271 |
| Pubmed | 2.76e-05 | 17 | 122 | 3 | 35969748 | ||
| Pubmed | 2.76e-05 | 17 | 122 | 3 | 16124007 | ||
| Pubmed | 2.76e-05 | 17 | 122 | 3 | 34622152 | ||
| Pubmed | 3.03e-05 | 250 | 122 | 7 | 33536335 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EDF1 BICRA POLR2A CHD3 POGZ SART1 WDR3 PHF2 BPTF MKI67 KMT2A SMARCC2 TAF1 | 3.21e-05 | 954 | 122 | 13 | 36373674 |
| Interaction | BRD3 interactions | BICRA MSH3 POGZ AR EIF3CL PLCD3 SART1 PHF2 BPTF CSNK2A1 MKI67 KMT2A SMARCC2 TAF1 TAF4B | 1.60e-07 | 494 | 116 | 15 | int:BRD3 |
| Interaction | CEBPA interactions | EDF1 SRSF5 ARHGAP15 BICRA POLR2A ETF1 BAG1 CHD3 POGZ PGK1 AR SART1 PHF2 PRR12 BPTF IGF2BP2 CSNK2A1 ZBTB21 MKI67 KMT2A SMARCC2 SDCBP RPL9 | 5.61e-07 | 1245 | 116 | 23 | int:CEBPA |
| Interaction | MEN1 interactions | SRSF5 POLR2A RPP38 CHD3 POGZ CBS SART1 WDR3 PRR12 BPTF IGF2BP2 TSR1 CSNK2A1 MKI67 KMT2A SMARCC2 TAF1 CSNK2A3 GOLGA2 RPL9 | 1.59e-06 | 1029 | 116 | 20 | int:MEN1 |
| Interaction | KMT2A interactions | KDM5B SRSF5 MYO1E POLR2A CHD3 AR CSNK2A1 MKI67 KMT2A SMARCC2 TAF1 | 2.03e-06 | 314 | 116 | 11 | int:KMT2A |
| Interaction | BRD2 interactions | BICRA BAG1 CHD3 POGZ AR PLCD3 PHF2 BPTF CSNK2A1 SMARCC2 TAF1 TAF4B | 6.93e-06 | 429 | 116 | 12 | int:BRD2 |
| Interaction | MLLT1 interactions | 7.14e-06 | 123 | 116 | 7 | int:MLLT1 | |
| Interaction | CIT interactions | KIF27 SRSF5 MYO1E POLR2A CHD3 POGZ SEC31A EIF3CL SART1 WDR3 PHF2 BPTF IGF2BP2 TSR1 AIFM1 CSNK2A1 MKI67 KMT2A SMARCC2 PATJ CSNK2A3 DDX4 RPL9 | 7.39e-06 | 1450 | 116 | 23 | int:CIT |
| Interaction | PAX6 interactions | 8.74e-06 | 366 | 116 | 11 | int:PAX6 | |
| Interaction | CT45A3 interactions | 1.52e-05 | 9 | 116 | 3 | int:CT45A3 | |
| Interaction | PARP1 interactions | MYO1E BICRA POLR2A BAG1 CHD3 MSH3 POGZ SEC31A WLS PGK1 AR SART1 WDR3 PHF2 BPTF GUF1 ZBTB21 MKI67 SMARCC2 RPL9 SLC27A4 | 1.80e-05 | 1316 | 116 | 21 | int:PARP1 |
| Interaction | SUPT5H interactions | BICRA POLR2A PLEKHJ1 CHD3 PGK1 SART1 PHF2 CSNK2A1 KMT2A GOLGA2 RPL9 | 2.40e-05 | 408 | 116 | 11 | int:SUPT5H |
| Interaction | KDM5B interactions | 2.45e-05 | 100 | 116 | 6 | int:KDM5B | |
| Interaction | H3C3 interactions | CHD3 MSH3 POGZ PHF2 BPTF TSR1 CSNK2A1 CCNL1 MKI67 KMT2A SMARCC2 TAF1 | 2.87e-05 | 495 | 116 | 12 | int:H3C3 |
| Interaction | CHD3 interactions | KDM5B SRSF5 CHD3 AR SART1 WDR3 BPTF IGF2BP2 TSR1 CSNK2A1 MKI67 KMT2A SMARCC2 TAF1 RPL9 | 2.95e-05 | 757 | 116 | 15 | int:CHD3 |
| Interaction | HNF4A interactions | 3.07e-05 | 275 | 116 | 9 | int:HNF4A | |
| Interaction | SMARCA2 interactions | 3.18e-05 | 346 | 116 | 10 | int:SMARCA2 | |
| Interaction | OPTN interactions | ROCK2 MYH3 MYH6 SEC31A CBS OPA1 CSNK2A1 ASS1 MKI67 CSNK2A3 SDCBP | 3.26e-05 | 422 | 116 | 11 | int:OPTN |
| Interaction | SUMO2 interactions | POLR2A CHD3 MSH3 POGZ PGK1 AR SART1 BPTF TSR1 ASS1 ZBTB21 MKI67 TAF1 | 3.61e-05 | 591 | 116 | 13 | int:SUMO2 |
| Interaction | PRKAG2 interactions | 4.52e-05 | 68 | 116 | 5 | int:PRKAG2 | |
| Interaction | HAGHL interactions | 5.10e-05 | 13 | 116 | 3 | int:HAGHL | |
| Interaction | MBD3 interactions | 5.30e-05 | 295 | 116 | 9 | int:MBD3 | |
| Interaction | ARK2N interactions | 5.66e-05 | 116 | 116 | 6 | int:ARK2N | |
| Interaction | FBF1 interactions | 6.01e-05 | 171 | 116 | 7 | int:FBF1 | |
| Interaction | CTR9 interactions | 6.15e-05 | 233 | 116 | 8 | int:CTR9 | |
| Interaction | FUBP1 interactions | 7.57e-05 | 309 | 116 | 9 | int:FUBP1 | |
| Interaction | SNRNP40 interactions | MYO1E RPP38 CHD3 POGZ SART1 WDR3 ITSN2 ZBTB21 MKI67 KMT2A SMARCC2 DHX35 RPL9 | 7.74e-05 | 637 | 116 | 13 | int:SNRNP40 |
| Interaction | LCOR interactions | 8.02e-05 | 242 | 116 | 8 | int:LCOR | |
| Interaction | TERF2IP interactions | RPP38 CHD3 MSH3 POGZ SART1 BPTF XAGE1A ZBTB21 MKI67 KMT2A SMARCC2 TAF1 | 8.19e-05 | 552 | 116 | 12 | int:TERF2IP |
| Interaction | KIF23 interactions | KIF27 SRSF5 MYO1E BAG1 CHD3 SEC31A CBS OPA1 TSFM WDR3 IGF2BP2 CSNK2A1 LRRC1 MKI67 CSNK2A3 RPL9 ALPG | 8.43e-05 | 1031 | 116 | 17 | int:KIF23 |
| Interaction | SIRT7 interactions | SRSF5 POLR2A POGZ PGK1 SART1 WDR3 BPTF IGF2BP2 TSR1 CSNK2A1 MKI67 KMT2A SMARCC2 RPL9 | 9.61e-05 | 744 | 116 | 14 | int:SIRT7 |
| Interaction | H3-3A interactions | CHD3 MSH3 POGZ AR PHF2 BPTF TSR1 CSNK2A1 CCNL1 ZBTB21 MKI67 KMT2A SMARCC2 TAF1 | 1.03e-04 | 749 | 116 | 14 | int:H3-3A |
| Interaction | POLR1G interactions | BICRA POLR2A POGZ WDR3 PHF2 BPTF TSR1 CSNK2A1 KMT2A SMARCC2 TAF1 | 1.22e-04 | 489 | 116 | 11 | int:POLR1G |
| Interaction | H2BC8 interactions | EDF1 CHD3 MSH3 POGZ PHF2 BPTF TSR1 ACTR6 MKI67 KMT2A SMARCC2 SDCBP | 1.22e-04 | 576 | 116 | 12 | int:H2BC8 |
| Interaction | GATA4 interactions | EDF1 RPP38 SEC31A WDR3 BPTF IGF2BP2 CSNK2A1 ZBTB21 KMT2A SMARCC2 | 1.33e-04 | 411 | 116 | 10 | int:GATA4 |
| Interaction | MECP2 interactions | FKBP15 KDM5B EDF1 SRSF5 POLR2A POGZ SEC31A OPA1 AARSD1 SART1 PHF2 BPTF IGF2BP2 TSR1 CSNK2A1 MKI67 SMARCC2 DHX35 ALPG | 1.34e-04 | 1287 | 116 | 19 | int:MECP2 |
| Interaction | CBX4 interactions | 1.86e-04 | 205 | 116 | 7 | int:CBX4 | |
| Interaction | RPS5 interactions | 1.96e-04 | 431 | 116 | 10 | int:RPS5 | |
| Interaction | SMARCC2 interactions | 2.06e-04 | 353 | 116 | 9 | int:SMARCC2 | |
| Interaction | ELF5 interactions | 2.09e-04 | 147 | 116 | 6 | int:ELF5 | |
| Interaction | MYH6 interactions | 2.11e-04 | 94 | 116 | 5 | int:MYH6 | |
| Interaction | EFTUD2 interactions | ROCK2 EDF1 SRSF5 MYO1E POLR2A ETF1 CHD3 CBS AR OPA1 AARSD1 SART1 TSR1 AIFM1 CSNK2A1 SMARCC2 DHX35 GOLGA2 SDCBP RPL9 | 2.16e-04 | 1449 | 116 | 20 | int:EFTUD2 |
| Interaction | HADH interactions | 2.17e-04 | 148 | 116 | 6 | int:HADH | |
| Interaction | DOT1L interactions | SRSF5 CHD3 AR SART1 WDR3 IGF2BP2 TSR1 A2ML1 MKI67 KMT2A SMARCC2 CSNK2A3 GOLGA2 RPL9 | 2.24e-04 | 807 | 116 | 14 | int:DOT1L |
| Interaction | RTF1 interactions | 2.33e-04 | 150 | 116 | 6 | int:RTF1 | |
| Interaction | IFI16 interactions | SRSF5 MYO1E POLR2A AR SART1 WDR3 IGF2BP2 TSR1 CSNK2A1 MKI67 SMARCC2 CSNK2A3 SDCBP | 2.39e-04 | 714 | 116 | 13 | int:IFI16 |
| Interaction | CBX1 interactions | 2.64e-04 | 288 | 116 | 8 | int:CBX1 | |
| Interaction | FBXO22 interactions | POLR2A ETF1 OPA1 SART1 TRANK1 CSNK2A1 ASS1 KMT2A CSNK2A3 GOLGA2 SDCBP | 2.87e-04 | 540 | 116 | 11 | int:FBXO22 |
| Interaction | YY1 interactions | 2.96e-04 | 454 | 116 | 10 | int:YY1 | |
| Interaction | FBRS interactions | 3.09e-04 | 102 | 116 | 5 | int:FBRS | |
| Interaction | KDM1A interactions | KDM5B ARHGAP15 POLR2A CHD3 POGZ TEX9 AR PRR12 CSNK2A1 ASB3 ITSN2 ZBTB21 SMARCC2 TAF1 GOLGA2 | 3.28e-04 | 941 | 116 | 15 | int:KDM1A |
| Interaction | TLE3 interactions | 3.28e-04 | 376 | 116 | 9 | int:TLE3 | |
| Interaction | SUZ12 interactions | SRSF5 MYO1E CHD3 PGK1 AR SART1 PHF2 BPTF TSR1 AIFM1 MKI67 SMARCC2 | 3.40e-04 | 644 | 116 | 12 | int:SUZ12 |
| Interaction | MBD2 interactions | 3.41e-04 | 161 | 116 | 6 | int:MBD2 | |
| Interaction | NFIX interactions | 3.46e-04 | 227 | 116 | 7 | int:NFIX | |
| Interaction | SIN3A interactions | 3.55e-04 | 380 | 116 | 9 | int:SIN3A | |
| Interaction | HTT interactions | ROCK2 EPS8 KDM5B MYH6 SRSF5 POLR2A BAG1 CHD3 CBS OPA1 PHF2 ACTR6 CSNK2A1 DDX4 CNTN1 | 3.58e-04 | 949 | 116 | 15 | int:HTT |
| Interaction | ANKRD36B interactions | 3.96e-04 | 60 | 116 | 4 | int:ANKRD36B | |
| Cytoband | 17p13.1 | 1.61e-05 | 118 | 121 | 5 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.26e-04 | 346 | 121 | 6 | chr17p13 | |
| Cytoband | 1p31.3 | 3.39e-04 | 51 | 121 | 3 | 1p31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 1.15e-03 | 172 | 121 | 4 | chr16p12 | |
| Cytoband | 4p12 | 1.27e-03 | 20 | 121 | 2 | 4p12 | |
| GeneFamily | Myosin heavy chains | 3.41e-07 | 15 | 74 | 4 | 1098 | |
| GeneFamily | PHD finger proteins | 3.36e-05 | 90 | 74 | 5 | 88 | |
| GeneFamily | FKBP prolyl isomerases | 5.14e-05 | 18 | 74 | 3 | 910 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 7.96e-07 | 171 | 113 | 8 | M2947 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 2.32e-05 | 196 | 113 | 7 | M8858 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN | 2.64e-05 | 200 | 113 | 7 | M8052 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 2.64e-05 | 200 | 113 | 7 | M6027 | |
| Coexpression | LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB | 4.16e-05 | 381 | 113 | 9 | M39231 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | HIVEP2 ARHGAP15 RALGPS2 CHD3 TSR1 ACTR6 CARD6 NIPAL1 TAF4B PATJ | 8.52e-06 | 327 | 111 | 10 | GSM538380_500 |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | GPR155 EPS8 MYO1E BICRA RALGPS2 ARHGAP17 MSH3 PHF2 MKI67 EEF2K | 3.32e-05 | 383 | 111 | 10 | GSM399448_500 |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.11e-05 | 195 | 114 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.18e-05 | 197 | 114 | 6 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.18e-05 | 197 | 114 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-PNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 198 | 114 | 6 | 6408653e956fedb284fa5e69ba8f4d620731f556 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.25e-05 | 199 | 114 | 6 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| Drug | B0683 | 1.34e-07 | 117 | 114 | 8 | CID006398969 | |
| Drug | blebbistatin | 1.95e-06 | 116 | 114 | 7 | CID003476986 | |
| Drug | NSC339663 | 4.78e-06 | 250 | 114 | 9 | CID000003892 | |
| Drug | pyrophosphate | ERVK-6 MYH2 MYH3 MYH6 TRIT1 MYH8 MYO1E POLR2A CBS ASS1 RARS2 TAF1 TAF4B ALG6 | 5.03e-06 | 654 | 114 | 14 | CID000001023 |
| Drug | formycin triphosphate | 5.63e-06 | 51 | 114 | 5 | CID000122274 | |
| Drug | NSC226080 | ROCK2 FKBP15 MYH2 MYH3 MYH6 MYH8 ABCB5 BAG1 AIFM1 ACTR6 CSNK2A1 CCNL1 FKBPL EEF2K FKBP2 | 8.45e-06 | 782 | 114 | 15 | CID000005040 |
| Drug | purealin | 1.07e-05 | 58 | 114 | 5 | CID006419303 | |
| Drug | NSC611747 | 1.13e-05 | 352 | 114 | 10 | CID000002534 | |
| Drug | AC1L1IZ2 | 2.28e-05 | 304 | 114 | 9 | CID000004795 | |
| Drug | oxanol | 2.60e-05 | 12 | 114 | 3 | CID000136505 | |
| Drug | 2bq7 | 3.64e-05 | 123 | 114 | 6 | CID006540267 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.51e-08 | 10 | 115 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.06e-07 | 12 | 115 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.06e-07 | 12 | 115 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.52e-07 | 13 | 115 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.89e-07 | 15 | 115 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Global developmental delay | 1.41e-05 | 133 | 115 | 6 | C0557874 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.57e-05 | 80 | 115 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 3.73e-05 | 48 | 115 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.74e-04 | 71 | 115 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 2.15e-04 | 75 | 115 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.75e-04 | 447 | 115 | 8 | C3714756 | |
| Disease | Combined oxidative phosphorylation deficiency | 4.07e-04 | 37 | 115 | 3 | cv:C4540031 | |
| Disease | Distal arthrogryposis | 5.32e-04 | 9 | 115 | 2 | cv:C0265213 | |
| Disease | glucagon-like peptide-1 measurement | 6.64e-04 | 10 | 115 | 2 | EFO_0008465 | |
| Disease | urate measurement, bone density | 7.27e-04 | 619 | 115 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | breast cancer (is_marker_for) | 8.07e-04 | 185 | 115 | 5 | DOID:1612 (is_marker_for) | |
| Disease | peak insulin response measurement | 1.14e-03 | 13 | 115 | 2 | EFO_0008000 | |
| Disease | Left Ventricle Remodeling | 3.01e-03 | 21 | 115 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 3.01e-03 | 21 | 115 | 2 | C0600519 | |
| Disease | kidney disease (biomarker_via_orthology) | 3.01e-03 | 21 | 115 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 3.30e-03 | 156 | 115 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Alzheimer's disease (is_marker_for) | 3.40e-03 | 257 | 115 | 5 | DOID:10652 (is_marker_for) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.61e-03 | 160 | 115 | 4 | DOID:5844 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GALEGQLKKKTGKLL | 146 | P43235 | |
| KKEAIIRINVGGKLL | 166 | Q9GZN1 | |
| KSVLKERGLKKIRLG | 356 | Q9BSF8 | |
| GKEKIGLKQIKYLVL | 431 | Q9NQI0 | |
| KKLSGGQKRKLTLGI | 526 | Q8WWZ4 | |
| KGLKGKGFVLLVKLA | 221 | Q9Y672 | |
| SGKLLIKLKDGRKVE | 376 | O95831 | |
| IKILKGLNLRIKSGE | 401 | Q2M3G0 | |
| RDVGLKILSNAKIKK | 676 | A8K2U0 | |
| RKKAKGALKRLIGII | 1051 | Q8IYW2 | |
| LKRKGLVKKVQAFLA | 306 | Q99933 | |
| QVIKILGTEKGKKNR | 221 | Q9BTE6 | |
| RKVALQEAKLKAKGL | 306 | Q9UK58 | |
| RDKALLKRLLKGVQK | 391 | Q8NEG7 | |
| EKQRLEKIKLEGGIK | 1201 | Q12830 | |
| VRKIKQGLGLKFAEL | 306 | P00966 | |
| LAKVGLRDKKIGRKA | 81 | Q96MI9 | |
| IRKLVGKRKNIEGKL | 341 | Q7Z4T9 | |
| KLLKALRVRKKTGGE | 1266 | Q9NZM3 | |
| LKRQAEGKKKLRKIG | 636 | Q8N442 | |
| GVKLLSKKIGERAIL | 326 | Q8NHS3 | |
| CVKELNGLKKLKRKG | 16 | Q96SQ7 | |
| KELEGLINTKRKRLK | 1091 | P20585 | |
| LLKKGIEALKQVTKR | 306 | Q9H3H1 | |
| KGALKKVLAKALGVN | 301 | Q8NGZ5 | |
| EGKRKLQIGVKKRVD | 26 | P26885 | |
| GKIKRLKKSAFVVLI | 266 | Q7Z3F1 | |
| KTVLKERGLKNIRIG | 306 | Q7Z5Y7 | |
| LGKIERAIGLKLRGK | 121 | O60869 | |
| KLQGRKTKEGLIGLL | 96 | P43897 | |
| KKKLKELVGEAIRRQ | 1221 | Q86VH2 | |
| LALKGGKKQIQKLEA | 1806 | P13535 | |
| LQKKARKELLGKGDL | 146 | Q765P7 | |
| KLKAVVEAKKLILGG | 446 | P55157 | |
| LKGGKKQIQKLEARV | 1811 | Q9UKX2 | |
| KLLRLKLGSGKVIKG | 226 | Q5T1M5 | |
| IGLLGLKRKQRKLKE | 1096 | Q9UGL1 | |
| TLGARKLKKLGNLKL | 626 | P10275 | |
| VGRLIGKEGRNLKKI | 286 | Q9Y6M1 | |
| KQRLKISLGKVGVKE | 1996 | P46013 | |
| KLTLDKLDVKGKRVV | 6 | P00558 | |
| QAIKKKLGKLGRQVL | 656 | Q86UT6 | |
| VKRELGKKLGELQEK | 576 | Q08379 | |
| GIGKLKKLSILKVDQ | 261 | Q9BTT6 | |
| VLFAILKKKSDKGVR | 221 | A6NKK0 | |
| ARILKGQKKDKLGPE | 71 | P10696 | |
| KELRKLVLQKDDKGI | 241 | O60313 | |
| GEKKIKLLTGKRVQL | 921 | O60313 | |
| LSFIKILLKRGGVKV | 16 | P87889 | |
| LSFIKILLKRGGVKV | 16 | Q9YNA8 | |
| LSFIKILLKRGGVKV | 16 | P62683 | |
| LSFIKILLKRGGVKV | 16 | P63145 | |
| LSFIKILLKRGGVKV | 16 | Q7LDI9 | |
| LSFIKILLKRGGVKV | 16 | P63130 | |
| LSFIKILLKRGGVKV | 16 | P62685 | |
| LSFIKILLKRGGVKV | 16 | P63126 | |
| LSFIKILLKRGGVKV | 16 | P62684 | |
| IKKLNEILQARGKKG | 331 | B5ME19 | |
| GNVKVLRKLLKKGRS | 21 | Q9Y575 | |
| KKIKREIKILENLRG | 76 | Q8NEV1 | |
| KKIVIRGHGLDKPKL | 106 | Q9UIM3 | |
| KSRKLLILVQKKGEA | 56 | Q9BX69 | |
| PLKIKLGLLGGKRKK | 291 | Q12873 | |
| DIAIGLLKKIQKKRG | 186 | Q9H5Z1 | |
| NGRLLGIITKKDVLK | 786 | P51795 | |
| KKKILAAKGGRVIIE | 421 | Q12860 | |
| RINKIGKKFGLKCEL | 91 | P35520 | |
| LKKEVVGKDLLKGSL | 136 | P53004 | |
| KKIKREIKILENLRG | 76 | P68400 | |
| VKTKILIKKGRGNLE | 956 | Q03164 | |
| ALDLEKKIGKSILGK | 511 | O00418 | |
| DGIRKLKLLDAKGKV | 86 | Q12929 | |
| IGLKLKIKQEAGLSK | 1306 | Q9NZM4 | |
| ILCKDQDGKIGLRLK | 116 | O00560 | |
| KLGKRVEKIIAIFGL | 141 | B5MCN3 | |
| FILKKKGLLQLASKG | 86 | Q6NVV3 | |
| TLRNKDVKGALKKVL | 291 | P59922 | |
| QGVLRRKTLLKEGKK | 461 | Q86X27 | |
| VKKKRNKAEKGLILA | 6 | Q2WGJ9 | |
| KLLESKGLLLKTIKG | 281 | Q5T160 | |
| FIGALQKRILDIGKK | 656 | Q92750 | |
| RLGKILKIHRNGKLL | 1081 | O75151 | |
| RLKAIGLQKIEDKKK | 51 | P78345 | |
| GDRKLIGAQKKKKLL | 216 | Q5T4F7 | |
| LFRIGAGASKLKKLK | 286 | Q68EM7 | |
| KKSRILLGKTGVIKE | 536 | P21675 | |
| LQKLGLGEGKLKRVL | 166 | Q7Z6M4 | |
| GVGKKEQLSVKKLRV | 966 | Q7Z3K3 | |
| GPKKGSVLKRRLVKL | 26 | Q9NW61 | |
| LQKAKIADGGKKLRK | 86 | Q53QZ3 | |
| LKGGKKQIQKLETRI | 1806 | P11055 | |
| NDLAKGRKQLKELKL | 331 | Q8NE31 | |
| AALELGLGRLKEKKK | 716 | Q9ULL5 | |
| DGLLNEHKKKVLKRL | 1886 | Q9ULL5 | |
| ALKGGKKQLQKLEAR | 1806 | P13533 | |
| KLLGKLKDIIKRHQG | 151 | Q8TAQ2 | |
| IEKLSGKEINGRKIK | 161 | Q13243 | |
| LSFIKILLKRGGVKV | 16 | P63128 | |
| ANGILKKVKKGSLLI | 116 | P31937 | |
| KKVGIKLLQEINKGG | 506 | Q8NHS4 | |
| ELLKRKLEQQEKGKG | 191 | Q86Y38 | |
| IKKALIIKLRRGKPG | 631 | Q9ULJ3 | |
| GKGRLALKTLSKKVR | 31 | Q2NL82 | |
| INVELSLLGKKKKRL | 41 | P32969 | |
| RDIFGGLVLLKVKAK | 51 | Q6P1M0 | |
| KRLKNGEELKGIFIK | 1091 | Q8NI35 | |
| EQLKGRVLVKGKKLP | 471 | Q8N3E9 | |
| LKSLKQRLKGKEGRV | 336 | P24928 | |
| TLRIGKLKAKIISKG | 211 | Q6P2S7 | |
| KNGKILLAKVELEKR | 656 | O75116 | |
| EKRLLNQKLGKIKTL | 176 | O43290 | |
| ERQKLLGLKVKGKPA | 41 | Q8WVY7 | |
| LKVGILHLGSRQKKI | 11 | Q9HD64 | |
| GVLLGQKEGKQVLKK | 741 | Q6PGP7 | |
| LKGQAKKRFNLLGIK | 436 | Q9C0G0 | |
| KKKINVGIGEIKDIR | 206 | Q5T9L3 | |
| DLRKGEKILILQGLK | 51 | Q9UNX4 | |
| LRKKLKGINKGQVSA | 926 | O15050 | |
| RKEDLGKKIALALNK | 496 | O94979 | |
| LEAIKLIRFGKKKNT | 81 | Q9NX45 | |
| KLERKLVGNILKERG | 1741 | P31629 | |
| GFKKQLKLIDVLKRQ | 351 | Q8N6V9 | |
| GKIHAKRLKLLLGEK | 96 | Q9H898 | |
| RIKQLLGKGLIKAAV | 151 | Q96QT4 | |
| VIRAKVVGKKLVKEG | 41 | P35625 | |
| GIGKENLAILEKIKK | 221 | Q7Z7E8 | |
| KIKKLIKSLEAARGN | 16 | P62495 | |
| QGPDKGLVKEVLKRK | 801 | Q12965 |